# Antifungal Effects of the Phloroglucinol Derivative DPPG Against Pathogenic Aspergillus fumigatus

**Authors:** Liyang Wang, Junying He, Hanzhong Feng, Qian Li, Meirong Song, Haoran Gou, Yongxing He, Kui Zhu

PMC · DOI: 10.3390/antibiotics14050499 · Antibiotics · 2025-05-13

## TL;DR

This study shows that a new compound called DPPG can effectively fight dangerous fungi like Aspergillus fumigatus by disrupting their cell membranes.

## Contribution

The novel phloroglucinol derivative DPPG was synthesized and shown to combat fungal infections through membrane disruption.

## Key findings

- DPPG exhibited strong antifungal activity against Aspergillus and Candida species.
- DPPG impaired hyphal growth and spore germination of A. fumigatus in vitro.
- DPPG reduced membrane fluidity and caused cellular leakage in fungal cells.

## Abstract

Background: Fungal infections pose an increasingly predominant threat to human and animal health. Modified compounds derived from chemo-diverse natural products offer enhanced therapeutic efficacies and promising approaches to combat life-threatening fungal pathogens. Methods: We performed biosynthetic gene clusters analysis of 2,4-diacetylchloroglucoside (DAPG) in 4292 shotgun metagenomes samples from the healthy and diseased skin. Then, we assessed the antifungal activity of DAPG and the derivative 2,4-diproylphloroglucinol (DPPG) against pathogenic fungi by minimum inhibitory concentrations. The inhibitory effects of DPPG were measured using hyphal growth assay and spore germination assay. Concurrently, the mechanism of DPPG on Aspergillus fumigatus was investigated in membrane permeability and fluidity. The therapeutic efficacy was evaluated in a Galleria mellonella infection model. Results: We observed a significantly higher abundance of bacteria harboring DAPG biosynthetic clusters on healthy skin compared to diseased skin. Further, we designed and synthesized a series of phloroglucinol derivatives based on DAPG and obtained an antifungal candidate DPPG. DPPG not only exhibited robust antifungal activity against Aspergillus spp. and Candida spp. but also impaired hyphal growth and spore germination of A. fumigatus in vitro. A mechanism study showed that DPPG reduced membrane fluidity and increased the leakage of cellular contents, resulting in membrane perturbation and fungal death. Lastly, the therapeutic efficacy of DPPG was confirmed in a G. mellonella infection model. Conclusions: Our study demonstrates that DPPG is a potent scaffold to combat invasive fungal infections.

## Linked entities

- **Chemicals:** DAPG (PubChem CID 16547), DPPG (PubChem CID 65144)
- **Species:** Aspergillus fumigatus (taxon 746128), Galleria mellonella (taxon 7137)

## Full-text entities

- **Diseases:** infection (MESH:D007239), Fungal infections (MESH:D009181)
- **Chemicals:** 2,4-diacetylchloroglucoside (-), DAPG (MESH:C047743), Phloroglucinol (MESH:D010696)
- **Species:** Galleria mellonella (greater wax moth, species) [taxon 7137], Homo sapiens (human, species) [taxon 9606], Aspergillus fumigatus (species) [taxon 746128], Fungi (kingdom) [taxon 4751], Candida [taxon 1535326]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12108449/full.md

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12108449/full.md

## References

54 references — full list in the complete paper: https://tomesphere.com/paper/PMC12108449/full.md

---
Source: https://tomesphere.com/paper/PMC12108449